IDEAYA Biosciences, Inc.
IDYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001676725
In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in IDEAYA Biosciences, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 96
- −6 vs. Q1 2022
- Shares held
- 35.4M
- +364.8K (+1.0%) vs. Q1 2022
- Total value
- $489.0M
- +$96.1M (+24.5%) vs. Q1 2022
- New holders
- 10
- 29 more added
- Sold out
- 16
- 37 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IDYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 285 | $3.80B |
| Q1 2026 | 254 | $3.16B |
| Q4 2025 | 246 | $3.32B |
| Q3 2025 | 224 | $2.56B |
| Q2 2025 | 204 | $2.04B |
| Q1 2025 | 207 | $1.54B |
| Q4 2024 | 206 | $2.36B |
| Q3 2024 | 209 | $2.91B |
| Q2 2024 | 199 | $2.90B |
| Q1 2024 | 204 | $3.47B |
| Q4 2023 | 157 | $2.35B |
| Q3 2023 | 144 | $1.61B |
| Q2 2023 | 138 | $1.33B |
| Q1 2023 | 128 | $625.4M |
| Q4 2022 | 117 | $835.0M |
| Q3 2022 | 112 | $667.1M |
| Q2 2022 | 96 | $489.0M |
| Q1 2022 | 103 | $392.9M |
| Q4 2021 | 110 | $820.7M |
| Q3 2021 | 91 | $837.9M |
| Q2 2021 | 84 | $533.4M |
| Q1 2021 | 89 | $558.6M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding IDEAYA Biosciences, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −48,838−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −46,200−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −42,900−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −39,939−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −24,590−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −18,997−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −18,133−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −11,787−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −10,125−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −3,376−100.0% | Sold out |
| Howe & Rusling Inc | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |